PRADAXA caps 110 mg 60 pce

7680613850150 CH-61385 B01AE07 06.03.0.

Active substances:

PRADAXA caps 110 mg 60 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6138502
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas 126.83 mg, acaciae gummi, acidum tartaricum, hypromellosum, dimeticonum, talcum, hydroxypropylcellulosum, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 171, E 132, aqua purificata, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Pradaxa 110 mg, Kapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/02/2024
Patient information leaflet
Français
26/02/2024
Patient information leaflet
Italien
26/02/2024
Professional SmPC
Allemand
26/02/2024
Professional SmPC
Français
26/02/2024
Professional SmPC
Italien
26/02/2024

Detailed composition

Substance Quantity Type Category
dabigatranum etexilatum
110.0 MG Substance Wirkstoff (Principe actif)
dabigatrani etexilati mesilas
126.83 MG Substance WIZUS
acaciae gummi
- Substance HNIDK
acidum tartaricum
- Substance HNIDK
hypromellosum
- Substance HNIDK
dimeticonum
- Substance HNIDK
talcum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
carrageenanum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 65.15
Specialties list
Yes
Generic
No
SL addition date: 01/07/2012

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
61385
Drug name
Pradaxa, Kapseln
Galenic form
KAPS
ATC Code
B01AE07
Authorization status
Z
Dispensation category
B
First authorization
29/05/2012
Authorization expiration date
31/12/9999
IT number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Packaging details

Description (FR)
PRADAXA caps 110 mg 60 pce
Description (DE)
PRADAXA Kaps 110 mg 60 Stk
Market launch
29/05/2012
Narcotic (BTM)
No

Available generics

Dabigatran Sandoz, Hartkapseln
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
CHF 150.10
View
Dabigatran Sandoz, Hartkapseln
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
CHF 150.10
View

Other packaging sizes

PRADAXA caps 110 mg 3 x 60 pce
3 x 60 KAP
View
Buy us a coffee Explore the data